A secondary explanation for our current findings is that DMD patients with the Gly16 polymorphism, by virtue of increased ADRB2 activity [29, 30], may have incurred additional skeletal muscle damage due to relatively higher intracellular concentrations of Ca2+ ([Ca2+]). This evidence concerns the gene ADRB2 and Duchenne muscular dystrophy.